$3.15
-0.10[-3.08%]
Last update: 8:30AM Get Real Time Here
Eton Pharmaceuticals
(NASDAQ:ETON)Eton Pharmaceuticals Stock (NASDAQ:ETON), Analyst Ratings, Price Targets, Predictions
Eton Pharmaceuticals Inc has a consensus price target of $10, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on December 11, 2023, August 11, 2023, and July 3, 2023. With an average price target of $9.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 206.88% upside for Eton Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Eton Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2023 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 217.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 217.46% | HC Wainwright & Co. | Raghuram Selvaraju | $9 → $10 | Maintains | Buy | Get Alert |
| 07/03/2023 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 185.71% | HC Wainwright & Co. | Raghuram Selvaraju | $10 → $9 | Maintains | Buy | Get Alert |
| 03/21/2023 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 217.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | → Buy | Get Alert |
| 09/26/2022 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 217.46% | HC Wainwright & Co. | Raghuram Selvaraju | $9 → $10 | Maintains | Buy | Get Alert |
| 07/25/2022 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 185.71% | HC Wainwright & Co. | Raghuram Selvaraju | $11 → $9 | Maintains | Buy | Get Alert |
| 03/22/2022 | ETON | Buy Now | Eton Pharmaceuticals | $3.15 | 249.21% | HC Wainwright & Co. | Raghuram Selvaraju | $14 → $11 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Eton Pharmaceuticals (ETON)?
The latest price target for Eton Pharmaceuticals (NASDAQ: ETON) was reported by HC Wainwright & Co. on December 11, 2023. The analyst firm set a price target for $10.00 expecting ETON to rise to within 12 months (a possible 217.46% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eton Pharmaceuticals (ETON)?
The latest analyst rating for Eton Pharmaceuticals (NASDAQ: ETON) was provided by HC Wainwright & Co., and Eton Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Eton Pharmaceuticals (ETON)?
There is no last upgrade for Eton Pharmaceuticals.
When was the last downgrade for Eton Pharmaceuticals (ETON)?
There is no last downgrade for Eton Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eton Pharmaceuticals (ETON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eton Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eton Pharmaceuticals was filed on December 11, 2023 so you should expect the next rating to be made available sometime around December 11, 2024.
Is the Analyst Rating Eton Pharmaceuticals (ETON) correct?
While ratings are subjective and will change, the latest Eton Pharmaceuticals (ETON) rating was a reiterated with a price target of $0.00 to $10.00. The current price Eton Pharmaceuticals (ETON) is trading at is $3.15, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.